Patient-Centric Development: Keeping the Patient at the Heart of Commercializing New Medicines

18 Jan 2023
13:30
Commercializing the Therapies of the Future Track

1:00pm Chair Introduction

Tom Whitehead, Founder, Emily Whitehead Foundation

 

1:05pm Presentation: TBC

Speaker TBC 

 

1:20pm Presentation: TBC

Speaker TBC

 

1:35pm Presentation: TBA

Farah Speer, Senior Vice President, AviadoBio

 

1:50pm Presentation: TBC

Speaker TBC

 

2:05pm Closing Panel with Q&A

With all session participants joined by:

Sven Kili, CEO, Antion Biosciences

Speakers

Farah Speer
Senior Vice President, Corporate Communications and External Relations
AviadoBio
Sven Kili
Chief Executive Officer
Antion Biosciences